Table 3 Reasons for Choosing ChEIs and Memantine
From: Clinicians’ prescription preferences for treating patients with Alzheimer’s disease in Shanghai
Reasons for choosing ChEIs | Proportions of clinicians (n = 64) | Reasons for choosing memantine | Proportions of clinicians (n = 64) |
|---|---|---|---|
Effectiveness | 46 (71.9 %) | moderate or severe AD | 22 (47.8 %) |
Safety | 23 (35.9 %) | controlling BPSD | 9 (19.6 %) |
Familiar with ChEIs | 7 (10.9 %) | poor response to ChEIs | 6 (13.0 %) |
Support of evidence-based research | 6 (9.4 %) | effectiveness | 6 (13.0 %) |
Convenience for patients oral taking | 5 (7.8 %) | fewer side-effect | 3 (6.5 %) |
Guidelines’ recommendation | 4 (6.3 %) | Patients had contraindications to ChEIs | 2 (4.3 %) |
The only available AD medication in the hospital | 3 (4.7 %) | combination use with ChEIs | 1 (2.2 %) |
Controlling BPSD | 1 (1.6 %) | support of evidence-based research | 1 (2.2 %) |